Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Similars in SciELO
Share
Revista Científica Ciencia Médica
Print version ISSN 1817-7433On-line version ISSN 2220-2234
Abstract
ALEGRE ANDRADE, Patricia. DEXMEDETOMIDINE AS AN ADYUVANT IN SEDATION FOR GYNECOLOGY. Rev Cient Cienc Méd [online]. 2021, vol.24, n.2, pp.82-88. Epub Dec 31, 2021. ISSN 1817-7433. https://doi.org/10.51581/rccm.v24i2.396.
Introduction:
We do not have experience on the use of intranasal dexmedetomidine for gynecological procedures in the environment.
Objectives:
To demonstrate the effects of intranasal use of dexmedetomidine in sedation for obstetric gynecological procedures.
Methods:
a prospective, longitudinal, single-blind, uncontrolled clinical trial was conducted; Taking 24 patients from a universe of 80 patients, 0.9 pg/kg of intranasal dexmedetomidine was administered prior to performing the procedure. it was processed in IBM-SPPS v.25 ®. Calculation of mean and SD in quantitative and p value < 0.05 significant.
Results:
average age of 32 years old; basal heart rate 70 beats / min, being significant after induction and at the end of the procedure; the mean arterial pressure remained between 82 to 73 mmHg, not significant;Visual Numeric Scale was found from 0 in 18 patients; during induction and maintenance with Target Control Infusion it was found between 2 ng / ml of remifentanil and 2 mcg / ml of propofol. There were no complications in 18 patients.
Conclusions:
it provides hemodynamic stability at the dose used without adverse effects after administration of dexmedetomidine and produces a reduction in the doses of induction and maintenance drugs.
Keywords : Dexmedetomidine; intranasal; curettage; sedation.